Allergan Must Comply With Implant MDL Discovery

By Jonathan Capriel · August 10, 2022, 4:40 PM EDT

Allergan can't delay handing over communications its sales representatives had with physicians regarding the safety and efficacy of its textured breast implants, a New Jersey federal judge has ruled, saying the...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

IN RE: ALLERGAN BIOCELL TEXTURED BREAST IMPLANT PRODUCTS LIABILITY LITIGATION

Case Number

2:19-md-02921

Court

New Jersey

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Date Filed

December 18, 2019